Recurrence · people with Buruli ulcer, non‐ulcerated lesions measuring less than 10 cm in diameter, aged 15 years or older
It is very uncertain whether rifampicin combined with streptomycin changes recurrence, 12 months compared with surgery alone (very low certainty).
1 finding from 1 review
Intervention not reported
Peripheral health centre with a prior probability of disease of 40% · Patients suspected to have visceral leishmaniasis disease 1
1 finding from 1 review
Intervention not reported
Referral centre with a prior probability of disease of 60% · Patients suspected to have visceral leishmaniasis disease 1
1 finding from 1 review
Intervention not reported
CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peripheral health centre with a prior probability of disease of 40% · Patients suspected to have visceral leishmaniasis disease 1
1 finding from 1 review
Intervention not reported
Referral centre with a prior probability of disease of 60% · Patients suspected to have visceral leishmaniasis disease 1
1 finding from 1 review
Intervention not reported
CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peripheral health centre with a prior probability of disease of 40% · Patients suspected to have visceral leishmaniasis disease 1
1 finding from 1 review
Intervention not reported
Referral centre with a prior probability of disease of 60% · Patients suspected to have visceral leishmaniasis disease 1
1 finding from 1 review
Intervention not reported
CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Vector density · People at risk of cutaneous leishmaniasis (CL) or visceral leishmaniasis (VL)
1 finding from 1 review
Intervention not reported
CL cases > 12 months · People at risk of cutaneous leishmaniasis (CL) or visceral leishmaniasis (VL)
The intervention probably leads to lower CL cases > 12 months (moderate certainty).
1 finding from 1 review
Intervention not reported
VL cases > 2 years · People at risk of cutaneous leishmaniasis (CL) or visceral leishmaniasis (VL)
1 finding from 1 review
Curea · people with Buruli ulcer, early lesions measuring less than 10 cm in diameter, aged 5 years or older
Rifampicin with clarithromycin showed no clear difference in curea compared with rifampicin with streptomycin (low certainty).
1 finding from 1 review
Cure · people who are being treated for active VL
1 finding from 1 review
Definitive cure · people who are being treated for active VL
1 finding from 1 review
Completion of treatment · people who are being treated for active VL
1 finding from 1 review
Resolution of symptoms · people who are being treated for active VL
1 finding from 1 review
Physical growth / weight gain · people who are being treated for active VL
1 finding from 1 review
Adverse outcomes · people who are being treated for active VL
1 finding from 1 review